Table 6 One-way ANOVA results for determination of proposed and reported methods of MZH in different pharmaceutical formulations
Pharmaceutical formulations | Source of variation | Sum of squares | Degree of freedom | Mean of squares | F-value | P-value | Critical F |
|---|---|---|---|---|---|---|---|
Navoproxin plus® tablets | Between group | 2.78 | 3 | 0.92 | 1.26 | 0.32 | 3.23 |
Within group | 11.75 | 16 | 0.73 | ||||
Total | 14.53 | 19 | |||||
Vomidoxine B6® tablets | Between group | 1.23 | 3 | 0.41 | 0.47 | 0.70 | 3.23 |
Within group | 13.84 | 16 | 0.86 | ||||
Total | 15.07 | 19 | |||||
Dizirest B6® tablets | Between group | 0.92 | 3 | 0.30 | 0.30 | 0.82 | 3.23 |
Within group | 16.43 | 16 | 1.02 | ||||
Total | 17.35 | 19 |